There’s evidence to suggest that the NF-κB pathway is an activated oncogenic pathway in both breast cancer cells and tumor tissues [23] and is intricately linked to facilitate breast cancer progression, including proliferation, apoptosis, metastasis and inflammation [24]. This evidence concerns the gene NFKB1 and breast carcinoma.